Men who consume large quantities of isoflavone-rich soy food have a decreased risk of localized prostate cancer.
SEATTLE—Cutting balloon ureteroplasty may be a safe and effective treatment option for anastomotic strictures resistant to conventional high-pressure balloon dilation, according to findings presented here at the Society of Interventional Radiology’s 31st Annual Scientific Meeting.
FDA has approved a new, coated version of Niaspan, a once-daily extended-release prescription niacin formulation for the treatment of lipid disorders.
SR Pharma PLC, of London, announced that the FDA has accepted its Investigational New Drug application (IND) for AKIi-5, a small interfering RNA (siRNA) therapeutic for the prevention of acute kidney injury (AKI) in high-risk patients undergoing major cardiovascular surgery.
Merck announced that Janumet—a single-tablet combination of sitagliptin (Januvia) and metformin—has cleared the FDA.
FDA’s Office of Cellular, Tissue and Gene Therapies Advisory Committee recommended to the agency that there is substantial evidence of efficacy and safety of Provenge (sipuleucel-T), made by Dendreon Corporation of Seattle, for treating patients with hormone refractory prostate cancer.
In recent years, the media have profiled several high-wattage celebrities in their late 30s and early 40s who are having children. The trend toward delayed marriage and parenting does not appear limited to Hollywood. Data from the 2000 census and the most recent National Survey of Family Growth (NSFG) reflect this pattern as well.